Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$226K Buy
4,309
+6
+0.1% +$317 0.03% 351
2026
Q1
$237K Buy
4,303
+130
+3% +$7.04K 0.03% 316
2025
Q4
$205K Buy
+4,173
New +$195K 0.03% 320

Other funds holding GSK

Fiduciary Financial Group's GSK Position: Q2 2026 in Review

Fiduciary Financial Group increased its GSK (GSK) stake by 0.14% in Q2 2026, buying an estimated $317 and bringing the position to 4,309 shares worth $226K. The position accounts for 0.03% of the portfolio, ranked #351.

Fiduciary Financial Group first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. The position peaked at $237K in Q1 2026. 433 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Fiduciary Financial Group held 4,309 shares of GSK worth $226K as of Q2 2026.
  • Fiduciary Financial Group bought 6 GSK shares in Q2 2026, an estimated $317.
  • GSK made up 0.03% of Fiduciary Financial Group's portfolio in Q2 2026, its #351 holding.
  • Fiduciary Financial Group first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
  • Fiduciary Financial Group's GSK position peaked at $237K in Q1 2026.
  • 433 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Fiduciary Financial Group's 13F filing for Q2 2026, filed 10 Jul 2026.